Recent Price Movement and Market Context
On 18 Dec 2025, Entero Healthcare Solutions recorded a closing price of Rs.969.05, marking the lowest level in the past year. The stock has experienced a consecutive three-day decline, resulting in a cumulative return of -2.96% over this period. Today’s performance also reflected a day change of -1.30%, underperforming its sector by approximately 1.58%. This downward trend places the stock below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a sustained period of price pressure.
In contrast, the broader market index, Sensex, opened flat but traded slightly lower by 0.15%, standing at 84,433.34 points. The Sensex remains within 2.04% of its 52-week high of 86,159.02 and is trading above its 50-day moving average, which itself is positioned above the 200-day moving average, signalling a generally bullish market environment. This divergence between Entero Healthcare Solutions and the broader market underscores the stock’s relative weakness over the recent period.
Long-Term Performance and Comparative Analysis
Over the last twelve months, Entero Healthcare Solutions has recorded a return of -33.77%, a stark contrast to the Sensex’s positive 5.30% return during the same timeframe. The stock’s 52-week high was Rs.1,564.95, indicating a substantial decline from its peak. This performance also trails the BSE500 index over one, three, and twelve-month periods, reflecting challenges in maintaining momentum relative to its peers.
Despite the recent price weakness, the company’s ability to service debt remains robust, with a Debt to EBITDA ratio of 1.33 times. This suggests that Entero Healthcare Solutions maintains a manageable debt level relative to its earnings before interest, taxes, depreciation, and amortisation, which is a positive indicator of financial stability amid price fluctuations.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Financial Growth and Profitability Metrics
Entero Healthcare Solutions has demonstrated healthy long-term growth in net sales, with an annual growth rate of 30.10%. Operating profit has shown a notable increase, rising by 127.38% over the same period. The company has reported positive results for seven consecutive quarters, with quarterly figures reaching record highs: Profit After Tax (PAT) at Rs.31.60 crores, net sales at Rs.1,570.95 crores, and Profit Before Depreciation, Interest and Taxes (PBDIT) at Rs.62.06 crores.
Return on Capital Employed (ROCE) stands at 8.6%, reflecting the company’s efficiency in generating profits from its capital base. Additionally, the enterprise value to capital employed ratio is 2.2, indicating a valuation that is attractive relative to the company’s capital utilisation. The stock currently trades at a discount compared to the average historical valuations of its peers within the retailing sector.
Over the past year, while the stock price has declined by 33.77%, the company’s profits have risen by 142%, highlighting a disconnect between earnings growth and market valuation. The Price/Earnings to Growth (PEG) ratio is 0.3, which suggests that the stock’s valuation relative to its earnings growth is comparatively low.
Shareholding and Institutional Interest
Institutional investors hold 24.32% of Entero Healthcare Solutions’ shares. These investors typically possess greater resources and analytical capabilities to assess company fundamentals, which may influence the stock’s market behaviour and valuation dynamics.
Why settle for Entero Healthcare Solutions ? SwitchER evaluates this Retailing small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Current Market Position
Entero Healthcare Solutions’ recent decline to Rs.969.05 marks a significant price level, reflecting a period of sustained downward movement relative to both its historical price range and broader market indices. The stock’s position below all major moving averages indicates continued pressure on the price front, while its financial metrics reveal a complex picture of strong profit growth alongside valuation challenges.
The company’s ability to maintain low leverage and deliver consistent quarterly profits contrasts with the stock’s subdued market performance. This divergence highlights the nuanced nature of market valuations, where earnings growth does not always translate immediately into share price appreciation.
As the stock trades near its 52-week low, it remains well below its peak price of Rs.1,564.95, underscoring the extent of the correction experienced over the past year. Meanwhile, the broader market environment remains relatively positive, with the Sensex trading near its yearly highs and maintaining bullish moving average trends.
Investors and market participants will continue to monitor Entero Healthcare Solutions’ price movements in the context of its financial fundamentals and sector performance, as the stock navigates this challenging phase.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Claim Your Free Year →
